Diclofenamide was approved in the United States in 1958 as Daranide to treat glaucoma, Subsequently, it was found effective in cases of therapy-resistant epilepsy.
The approval of Diclofenamide (Daranide) for glaucoma in 1958 paved the way for its later application in treating therapy-resistant epilepsy.